I agree that this site is using cookies. You can find further informations here.
X
Arieta, Alfredo García
137  results:
Search for persons X
?
1

The bioequivalence study design recommendations for immedia..:

Fernandes, Eduardo Agostinho Freitas ; Oudtshoorn, Joy van ; Tam, Andrew...
Journal of Pharmacy & Pharmaceutical Sciences.  27 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Regulatory Requirements and Applications of Physiologically..:

, In: ADME Processes in Pharmaceutical Sciences,
Cuquerella-Gilabert, Marina ; Merino-Sanjuán, Matilde ; García-Arieta, Alfredo.. - p. 193-219 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Bioequivalence risk assessment of oral formulations contain..:

Reig-López, Javier ; Cuquerella-Gilabert, Marina ; Bandín-Vilar, Enrique...
European Journal of Pharmaceutics and Biopharmaceutics.  199 (2024)  - p. 114293 , 2024
Link: https://doi.org/10.1016/..
 
?
4

A Two-Way Proposal for the Determination of Bioequivalence ..:

Paixao, Paulo ; Garcia Arieta, Alfredo ; Silva, Nuno...
Pharmaceutics.  16 (2024)  5 - p. 598 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Alternative Pharmacokinetic Metrics in Single-Dose Studies ..:

Mangas-Sanjuán, Víctor ; Simón, Marta ; González-Rojano, Esperanza...
Pharmaceutics.  15 (2023)  2 - p. 409 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Regulatory Requirements for the Development of Second-Entry..:

García-Arieta, Alfredo ; Gordon, John ; Gwaza, Luther..
Pharmaceutics.  15 (2023)  2 - p. 601 , 2023
Link: https://doi.org/10.3390/..
 
?
7

Regulatory Requirements for the Development of Second-Entry..:

Alfredo García-Arieta ; John Gordon ; Luther Gwaza..
https://www.mdpi.com/1999-4923/15/2/601.  , 2023
Link: https://doi.org/10.3390/..
 
?
8

Regulatory Requirements for the Development of Second-Entry..:

García-Arieta, Alfredo ; Gordon, John ; Gwaza, Luther..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961670/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Selective serotonin reuptake inhibitors and suicidality in ..:

Manolis, Efthymios ; García-Arieta, Alfredo ; Lindahl, Anders...
https://repository.publisso.de/resource/frl:6447499.  , 2023
Link: https://repository.publi..
 
?
10

Using mechanistic models to support development of complex ..:

Manolis, Efthymios ; García Arieta, Alfredo ; Lindahl, Anders...
https://repository.publisso.de/resource/frl:6447480.  , 2023
Link: https://repository.publi..
 
?
11

Alternative Pharmacokinetic Metrics in Single-Dose Studies ..:

Víctor Mangas-Sanjuán ; Marta Simón ; Esperanza González-Rojano...
Pharmacokinetics and Pharmacodynamics.  , 2023
Link: https://doi.org/10.3390/..
 
?
12

Alternative Pharmacokinetic Metrics in Single-Dose Studies ..:

Víctor Mangas-Sanjuán ; Marta Simón ; Esperanza González-Rojano...
https://www.mdpi.com/1999-4923/15/2/409.  , 2023
Link: https://doi.org/10.3390/..
 
?
13

Regulatory Requirements for the Development of Second-Entry..:

Alfredo García-Arieta ; John Gordon ; Luther Gwaza..
Drug Delivery and Controlled Release.  , 2023
Link: https://doi.org/10.3390/..
 
?
14

Alternative Pharmacokinetic Metrics in Single-Dose Studies ..:

Mangas-Sanjuán, Víctor ; Simón, Marta ; González-Rojano, Esperanza...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963605/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
15

Level A IVIVC for immediate release tablets confirms in viv..:

Cámara-Martinez, I. ; Blechar, J.A. ; Ruiz-Picazo, A....
International Journal of Pharmaceutics.  614 (2022)  - p. 121415 , 2022
Link: https://doi.org/10.1016/..
 
1-15